Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Orthocell appoints specialist US-based nerve surgeons to medical advisory board

Published 29/03/2023, 10:45 am
© Reuters.  Orthocell appoints specialist US-based nerve surgeons to medical advisory board
PLXS
-
PLEX
-

Orthocell Ltd (ASX:OCC) has tapped two internationally recognised orthopaedic surgeons specialising in nerve transfer and peripheral nerve repair, Professor Christopher Dy and Professor David Brogan, to the company’s Medical Scientific Advisory Board (MSAB).

Globally recognised nerve reconstructive surgeons

Orthocell managing director Paul Anderson said: “We are delighted to welcome Professors Dy and Brogan to the Orthocell MSAB.

“Both are globally recognised nerve reconstructive surgeons, with a passion for translating medical research and delivering the highest quality patient care.

“We are also delighted to be collaborating with Washington University, one of the leading centres for nerve reconstructive surgery in the USA.

“These appointments, along with the recent appointment of Dr Ravi Thadhani to the Orthocell board of directors, add significant depth to our US team and ability to execute our commercialisation plans.”

Professors Dy and Brogan are based at Washington University and Barnes-Jewish Orthopedic Center, one of the US’s leading academic research institutions and hospitals,and have been appointed to assist with clinical development and US market access for Orthocell’s nerve repair medical device.

Comprehensive research program

Professors Christopher Dy and David Brogan are orthopaedic surgeons who specialise in the treatment of nerve injuries while also leading a comprehensive research program that is directly relevant to patients, clinicians, scientists, and policy-makers.

Their translational research is focused on the epidemiologic, economic, and clinical analysis of peripheral and brachial plexus nerve injuries.

Both surgeons bring a wealth of clinical and research expertise, including significant experience advancing pre-clinical and clinical research programs.

With these additions to the specialist advisory team, Orthocell is ideally positioned to drive its market-leading nerve repair medical device into the US market.

About Dr Christopher Dy

Professor Dy is an internationally recognised orthopaedic surgeon specialising in the treatment of brachial plexus and peripheral nerve injuries (upper and lower limbs), using nerve transfers, nerve reconstructions, nerve decompressions and carpal and cubital tunnel release.

Dr Dy has published numerous peer-reviewed research and clinical papers in top-tier journals, in the areas of brachial plexus and peripheral nerve injuries.

He has also received multiple awards for his contributions to research and advancing treatment of nerve injuries.

About Professor David Brogan

Professor David Brogan is a multi-credentialled surgeon and health professional who specialises in treating conditions of the hand and upper extremity, including fractures, arthritis of the wrist, elbow and hand.

He has a patient-centric approach with special expertise in treating nerve injuries, including peripheral nerve injuries, compression neuropathies – carpal tunnel, peroneal nerve injury, brachial plexus injury – complex microsurgical reconstruction, and upper extremity trauma.

Dr Brogan has received multiple awards for his contributions to research and advancing treatment of nerve injuries.

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.